European ADRs Higher

American depository receipts of European stocks were 0.2% higher at 126.47 on the Bank of New York Mellon Europe ADR Index on Monday morning.

Gainers in Continental Europe were led by Oasmia Pharmaceutical (OASM), a Sweden-based pharmaceutical company, 10.5% higher, followed by Natuzzi (NTZ), an Italian furniture manufacturer, up by 3.0% and Forward Pharma (FWP), a Danish biopharmaceutical company, 2.6% higher. TiGenix (TIG), a Belgium-based biopharmaceutical company, was up by 1.5%. In the UK, Motif Bio (MTFB), a clinical-stage biopharmaceutical company, was 4.0% higher, followed by BHP Billiton (BBL), a mining company, up by 3.4% and Avadel (AVDL), a specialty pharmaceutical company, 1.9% higher. Amarin (AMRN), a biopharmaceutical company, was up by 1.6%.

Decliners in Continental Europe were led by Nabriva Therapeutics (NBRV), an Austria-based clinical-stage biopharmaceutical company, 2.4% lower, followed by voxelJet (VJET), a German three-dimensional printer manufacturer, down by 1.5% and Telecom Italia – Savings (TI.A), an Italian telecommunications company, 1.2% lower. And, Banco Bilbao Vizcaya Argentaria (BBVA), a Spanish financial group, down by 1.1%.

By Stephen Holmes